GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (HKSE:02160) » Definitions » EV-to-Revenue

MicroPort CardioFlow Medtech (HKSE:02160) EV-to-Revenue : 3.85 (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is MicroPort CardioFlow Medtech EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, MicroPort CardioFlow Medtech's enterprise value is HK$1,416.3 Mil. MicroPort CardioFlow Medtech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$367.7 Mil. Therefore, MicroPort CardioFlow Medtech's EV-to-Revenue for today is 3.85.

The historical rank and industry rank for MicroPort CardioFlow Medtech's EV-to-Revenue or its related term are showing as below:

HKSE:02160' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.82   Med: 14.79   Max: 374.9
Current: 4.18

During the past 6 years, the highest EV-to-Revenue of MicroPort CardioFlow Medtech was 374.90. The lowest was 2.82. And the median was 14.79.

HKSE:02160's EV-to-Revenue is ranked worse than
59.45% of 831 companies
in the Medical Devices & Instruments industry
Industry Median: 3.24 vs HKSE:02160: 4.18

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-26), MicroPort CardioFlow Medtech's stock price is HK$1.04. MicroPort CardioFlow Medtech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.16. Therefore, MicroPort CardioFlow Medtech's PS Ratio for today is 6.67.


MicroPort CardioFlow Medtech EV-to-Revenue Historical Data

The historical data trend for MicroPort CardioFlow Medtech's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort CardioFlow Medtech EV-to-Revenue Chart

MicroPort CardioFlow Medtech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - - 27.44 15.38 7.67

MicroPort CardioFlow Medtech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.44 - 15.38 - 7.67

Competitive Comparison of MicroPort CardioFlow Medtech's EV-to-Revenue

For the Medical Devices subindustry, MicroPort CardioFlow Medtech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MicroPort CardioFlow Medtech's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort CardioFlow Medtech's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where MicroPort CardioFlow Medtech's EV-to-Revenue falls into.



MicroPort CardioFlow Medtech EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

MicroPort CardioFlow Medtech's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1416.264/367.745
=3.85

MicroPort CardioFlow Medtech's current Enterprise Value is HK$1,416.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MicroPort CardioFlow Medtech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$367.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroPort CardioFlow Medtech  (HKSE:02160) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

MicroPort CardioFlow Medtech's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1.04/0.156
=6.67

MicroPort CardioFlow Medtech's share price for today is HK$1.04.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.16.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroPort CardioFlow Medtech EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of MicroPort CardioFlow Medtech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort CardioFlow Medtech (HKSE:02160) Business Description

Traded in Other Exchanges
Address
No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.
Executives
China Renaissance Holdings Limited 2201 Interest of corporation controlled by you
Hua Jie Tian Jin Yi Liao Tou Zi He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Shang Hai Hua Hao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo 2101 Beneficial owner
Tian Jin Hua Jie Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo 2201 Interest of corporation controlled by you
Tian Jin Hua Qing Qi Ye Guan Li Zi Xun You Xian Gong Si 2201 Interest of corporation controlled by you
Microport Scientific Corporation 2201 Interest of corporation controlled by you
Shanghai Microport Limited 2101 Beneficial owner
China International Capital Corporation Limited 2201 Interest of corporation controlled by you
Cicc Capital Management Co., Ltd. 2201 Interest of corporation controlled by you
Cicc Kangrui I (ningbo) Equity Investment Limited Partners (limited Partnership) 2101 Beneficial owner
Cicc Kangzhi (ningbo) Equity Investment Management Co., Ltd. 2201 Interest of corporation controlled by you

MicroPort CardioFlow Medtech (HKSE:02160) Headlines

No Headlines